Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek

Clinical trial NCT05504915 · COMPLETED

Trial details

NCT number: NCT05504915
Sponsor: Osijek University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Diseases Crohn Disease Colitis, Ulcerative

Start date: 2022-05-01
Primary completion: 2023-05-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.